日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Denani et al. Pseudovirus-Based Neutralization Assays as Customizable and Scalable Tools for Serological Surveillance and Immune Profiling. Pathogens 2025, 14, 1129

更正:Denani 等人,《基于假病毒的中和试验作为可定制和可扩展的血清学监测和免疫分析工具》,《病原体》2025,14,1129

Denani, Caio Bidueira; Setatino, Bruno Pimenta; Pereira, Denise; Horbach, Ingrid Siciliano; Azevedo, Adriana Souza; Coutinho, Gabriela; Ferroco, Clara Lucy; Xavier, Janaína; Leite, Robson; Santos, Ewerton; Maia, Maria de Lourdes; Schwarcz, Waleska Dias; Sousa, Ivanildo Pedro

Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity

在非流行地区,对一组成人和儿童单剂接种17DD黄热病疫苗的免疫原性及其与登革热和寨卡病毒血清阳性率的关联性研究

Saucha, Camylla Veloso Valença; Maia, Maria de Lourdes de Sousa; Sousa, Eduardo Sérgio Soares; de Oliveira, Patrícia Mouta Nunes; Xavier, Janaína Reis; de Castro, Thalita da Matta; Cruz, Robson Leite de Souza; Schwarcz, Waleska Dias; Pereira, Renata Carvalho; Azevedo, Adriana de Souza; de Filippis, Ana Maria Bispo; Ferroco, Clara Lucy de Vasconcellos; Pizzini, Geovanna de Lima Cunha; Brum, Ricardo Cristiano de Souza; Secundino, Leonardo; Andrade, Maria de Fátima de Sousa; de Oliveira, Raquel de Vasconcellos Carvalhaes; Simões, Marisol; Cerbino-Neto, José; Martins-Filho, Olindo Assis; Campi-Azevedo, Ana Carolina; de Lima, Sheila Maria Barbosa; Camacho, Luiz Antonio Bastos

Pseudovirus-Based Neutralization Assays as Customizable and Scalable Tools for Serological Surveillance and Immune Profiling

基于假病毒的中和试验作为可定制和可扩展的血清学监测和免疫分析工具

Denani, Caio Bidueira; Setatino, Bruno Pimenta; Pereira, Denise; Horbach, Ingrid Siciliano; Azevedo, Adriana Souza; Coutinho, Gabriela; Ferroco, Clara Lucy; Xavier, Janaína; Leite, Robson; Santos, Ewerton; Maia, Maria de Lourdes; Schwarcz, Waleska Dias; Sousa, Ivanildo Pedro

Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses

一项关于新冠疫苗(重组疫苗)第三剂接种后免疫原性的同源等效性研究,该研究在第二剂接种后间隔六个月,并与前两剂接种间隔八周和十二周的情况进行了比较。

Vianna, Clarice Monteiro; da Silva E Sá, Gloria Regina; Seid, Maria Vitória Hadland; Camacho, Luiz Antonio Bastos; Xavier, Janaína Reis; da Gama, Vitor Cardoso; de Castro, Thalita da Matta; Dos Santos, Ewerton Alves Portela; de Almeida, Camila Dias; Cruz, Robson Leite de Souza; Siqueira, Marilda; Maia, Maria de Lourdes de Sousa; Ferroco, Clara Lucy de Vasconcellos; de Araújo, Mia Ferreira; Tort, Luis Fernando López; Caetano, Braulia Costa